For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

9 July 2009
Health professionals are encouraged to participate in the National Prescribing Service’s (NPS) Clinical e-audit: Type 2 diabetes during National Diabetes Week, 12-18 July.
Optimising management of type 2 diabetes helps GPs review drug therapy and achieve target levels in patients with type 2 diabetes, providing instantaneous feedback based on clinical data entered.
“National Diabetes Week is not just about acknowledging the prevalence of this disease. It puts diabetes at the top of people’s minds and encourages consideration and discussion about the risk factors of diabetes,” NPS CEO, Dr Lynn Weekes said.
“Health professionals can expect to see an increase in the number of people with questions about type 2 diabetes over the next month as the campaign messages are heard.”
“This is an ideal time to participate in the type 2 diabetes clinical e-audit which focuses on the use of oral anti-diabetic agents and insulin, frequency of monitoring and the management of coexisting dyslipidaemia and hypertension,” Dr Weekes said.
The e-audit is a desktop software program that is independent of prescribing software, with data securely submitted online. Participants are required to review 20 patients.
Participation in Clinical e-audit: Type 2 diabetes assists GPs to:
The e-audit is recognised by the RACGP quality assurance and continuing professional development program, offering total points 40 (category 1) in the 2008-2010 triennium. It is also recognised in the ACRRM professional development program, offering 30 points (extended skills).
Participation is open until 16 April 2010. For more information or to enrol visit www.nps.org.au/healthpro.
Other professional resources which will be promoted throughout National Diabetes Week include the Heart Foundation’s Absolute Cardiovascular Risk calculator and National Vascular Disease Prevention Alliance guidelines, which make recommendations for assessing absolute CVD risk in adults aged 45-74 years (35 years and above for Aboriginal or Torres Strait Islander adults).
ENDS
The National Prescribing Service Limited (NPS) is an independent, non-profit organisation for Quality Use of Medicines funded by the Australian Government Department of Health and Ageing.
Media enquiries
Contact us
Date published: 2009-07-09 19:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.